STERIS Corp. (STE)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
CEO:
Daniel A. Carestio
Employees:
16,000
70 SIR JOHN ROGERSON'S QUAY, DUBLIN, IRELAND 2
35312322000

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemicals, and washer disinfectors.

Data derived from most recent annual or quarterly report
Market Cap 21.971 Billion Shares Outstanding100.13 Million Avg 30-day Volume 352.513 Thousand
P/E Ratio186.0037 Dividend Yield0.8356 EPS1.25
Price to Revenue4.3639 Debt to Equity0.4999 EBITDA857.309 Million
Price to Book Value3.5981 Operating Margin5.8726 Enterprise Value25.084 Billion
Current Ratio2.29 EPS Growth-0.681 Quick Ratio1.236
1 Yr BETA 0.9669 52-week High/Low 253.43 / 157.64 Profit Margin2.3368
Operating Cash Flow Growth-1.5628 Free Cash Flow to Firm (FCFF) TTM 389.269 Million Free Cash Flow to Equity (FCFE) TTM178.244 Million
Altman Z-Score3.8384
Earnings Report2023-11-08
View SEC Filings from STE instead.

View recent insider trading info

STERIS Corp. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding STE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding STE

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-08-07 by ALEGRIA ESTHER M.
  • 4: filed on 2023-06-06 by XILAS ANDREW
  • 4: filed on 2023-06-06 by MADSEN JULIA
  • 4: filed on 2023-06-05 by FRASER MARY CLARE
  • 4: filed on 2023-06-05 by MADSEN JULIA
  • 4: filed on 2023-06-02 by ALEGRIA ESTHER M.
  • 4: filed on 2023-06-02 by FRASER MARY CLARE
  • 4: filed on 2023-06-02 by MADSEN JULIA
  • 4: filed on 2023-06-02 by XILAS ANDREW
  • 4: filed on 2023-06-02 by MAJORS CARY L

    • Events (8k)

  • 8-K: filed on 2019-03-08:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-02-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-12-04:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-11-06:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-02-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-01-08:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2017-11-20:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2017-11-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    KOSECOFF JACQUELINE B

    • Director
    		 0 2023-08-03 2

    FELDMANN CYNTHIA L

    • Director
    		 0 2023-08-03 2

    HOLLAND CHRISTOPHER S

    • Director
    		 0 2023-08-03 1

    SOHI MOHSEN

    • Director
    		 0 2023-08-03 2

    BREEDEN RICHARD C

    • Director
    		 0 2023-08-03 4

    STEEVES RICHARD MARTIN

    • Director
    		 0 2023-08-03 1

    MARTIN PAUL EDWARD

    • Director
    		 0 2023-08-03 1

    SHAH NIRAV R

    • Director
    		 0 2023-08-03 1

    ALEGRIA ESTHER M.

    • Director
    		 0 2023-08-03 4

    ZANGERLE JOHN ADAM SR. VP, GEN COUNSEL, AND SEC.

    • Officer
    		 30,344 2023-06-02 3

    CARESTIO DANIEL A PRESIDENT AND CEO

    • Officer
    • Director
    		 47,106 2023-06-02 4

    BURTON KAREN L VP, CONTROLLER & CAO

    • Officer
    		 6,785 2023-06-02 3

    MADSEN JULIA SENIOR VP, LIFE SCIENCES

    • Officer
    		 8,722 2023-06-02 3

    XILAS ANDREW SVP AND GM, DENTAL

    • Officer
    		 5,894 2023-06-02 3

    FRASER MARY CLARE SVP & CHIEF HRO

    • Officer
    		 9,328 2023-06-01 2

    TOKICH MICHAEL J SR. VICE PRES., CFO

    • Officer
    		 45,991 2023-05-31 1

    TAMARO RENATO V.P. & CORPORATE TREASURER

    • Officer
    		 6,677 2023-05-31 1

    MAJORS CARY L SVP AND PRESIDENT, HEALTHCARE

    • Officer
    		 13,393 2023-05-31 3

    LEWIS DAVID B

    • Director
    		 8,245 2021-07-21 0

    ROSEBROUGH WALTER M JR PRESIDENT & CEO

    • Officer
    • Director
    		 51,405 2020-11-09 0

    BARDWELL KATHLEEN SR.V. P. & C.C.O.

    • Officer
    		 17,428 2019-06-28 0

    WILSON LOYAL W

    • Director
    		 24,000 2019-06-04 0

    DEZWAAN MICHIEL V.P., HUMAN RESOURCES & CHRO

    • Officer
    		 8,122 2019-05-31 0

    KHAN GULAM AMJAD SR. V.P., PROCEDURAL SOLUTIONS

    • Officer
    		 14,685 2019-05-31 0

    COWARD ADRIAN VINCENT SR. V P, HEALTHCARE SPEC SERV

    • Officer
    		 25,119 2019-05-31 0

    WOOD MICHAEL B

    • Director
    		 16,631 2019-05-16 0

    CARESTIO DANIEL A SR VP AND CHIEF OPERATING OFF

    CARESTIO DANIEL A SR VP AND CHIEF OPERATING OFF

    • Officer
    		 0 2019-03-28 4

    NICHOL DUNCAN K

    • Director
    		 No longer subject to file 2019-03-28 0

    PAHWA SUDHIR K SR. V.P., IPT

    • Officer
    		 13,162 2018-06-01 0

    WAREHAM JOHN P

    • Director
    		 0 2017-08-09 0

    FORSYTHE SUZANNE V V. P. - HUMAN RESOURCES

    • Officer
    		 13,002 2016-10-03 0

    MCMULLEN KEVIN M

    • Director
    		 26,338 2015-11-09 0

    EDWARDS BRUCE A

    • Director
    		 0 2015-11-02 0

    JOHNSON DAVID ALLEN SR. VP. SURGICAL SOLUTIONS

    • Officer
    		 32,037 2015-08-10 0

    MOSS ROBERT E SENIOR VICE PRESIDENT

    • Officer
    		 56,243 2015-06-01 0

    CHAPMAN TIMOTHY L SR VP & GRP. PRES., HEALTHCARE

    • Officer
    		 33,578 2014-05-20 0

    MCGINLEY MARK D SR. VP, GEN COUNSEL, AND SEC.

    • Officer
    		 24,651 2013-05-31 0

    BURKE PETER A SR. VP & CHIEF TECH. OFFICER

    • Officer
    		 18,868 2013-05-30 0

    AAMOTH WILLIAM L V P - CORPORATE TREASURER

    • Officer
    		 9,928 2013-05-30 0

    FIELDS ROBERT H.

    • Director
    		 7,514 2010-02-03 0

    BLACKMORE R GREGOIRE SVP & GROUP PRESIDENT, L.S.

    • Officer
    		 11,149 2009-09-08 0

    REIS GERARD J SR. VP, GOVT. & ADMINISTRATION

    • Officer
    		 0 2009-05-21 0

    LANCASTER RAYMOND A

    • Director
    		 8,163 2008-07-31 0

    RICHEY JOSEPH B II

    • Director
    		 126,334 2008-07-31 0

    VOYZEY JOHN NAVIN

    • VP & GEN. MGR. - LIFE SCIENCES
    		 5,525 2008-05-21 0

    VINNEY LES C PRESIDENT AND CEO

    • Officer
    		 315,200 2007-09-11 0

    IMMEL CHARLES L SR VP & GRP PRES. HEALTH CARE

    • Officer
    		 30,400 2007-07-27 0

    MCCULLAGH PATRICK J VP, QUALITY SYSTEMS ENG & REG

    • Officer
    		 10,993 2007-07-27 0

    BRLAS LAURIE SENIOR VICE PRESIDENT AND CFO

    • Officer
    		 11,250 2006-09-12 0

    FISH PATRICIA K SR. VICE PRES, HUMAN RESOURCES

    • Officer
    		 8,000 2006-09-12 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    KOSECOFF JACQUELINE B - Director

    		2023-08-07 16:35:30 -0400 2023-08-03 A 525 a 5,688 direct

    SOHI MOHSEN - Director

    		2023-08-07 16:35:20 -0400 2023-08-03 A 2,443 a 2,443 direct

    SOHI MOHSEN - Director

    		2023-08-07 16:35:20 -0400 2023-08-03 A 831 a 4,994 direct

    SOHI MOHSEN - Director

    		2023-08-07 16:35:20 -0400 2023-08-03 A 279 $225.50 a 5,273 direct

    SHAH NIRAV R - Director

    		2023-08-07 16:35:23 -0400 2023-08-03 A 1,544 a 1,544 direct

    SHAH NIRAV R - Director

    		2023-08-07 16:35:23 -0400 2023-08-03 A 525 a 5,522 direct

    ALEGRIA ESTHER M. - Director

    		2023-08-07 16:35:26 -0400 2023-08-03 A 1,050 a 1,421 direct

    STEEVES RICHARD MARTIN - Director

    		2023-08-07 16:35:28 -0400 2023-08-03 A 1,545 a 1,545 direct

    STEEVES RICHARD MARTIN - Director

    		2023-08-07 16:35:28 -0400 2023-08-03 A 525 a 7,846 direct

    STEEVES RICHARD MARTIN - Director

    		2023-08-07 16:35:28 -0400 2023-08-03 A 364 $225.50 a 8,210 direct

    STEEVES RICHARD MARTIN - Director

    		2023-08-07 16:35:28 -0400 2023-08-03 A 195 $76.72 a 1,740 direct

    KOSECOFF JACQUELINE B - Director

    		2023-08-07 16:35:30 -0400 2023-08-03 A 1,544 a 1,544 direct

    FELDMANN CYNTHIA L - Director

    		2023-08-07 16:35:15 -0400 2023-08-03 A 525 a 7,147 direct

    KOSECOFF JACQUELINE B - Director

    		2023-08-07 16:35:30 -0400 2023-08-03 A 364 $225.50 a 6,052 direct

    KOSECOFF JACQUELINE B - Director

    		2023-08-07 16:35:30 -0400 2023-08-03 A 261 $76.72 a 1,805 direct

    BREEDEN RICHARD C - Director

    		2023-08-07 16:35:07 -0400 2023-08-03 A 1,544 a 1,544 direct

    BREEDEN RICHARD C - Director

    		2023-08-07 16:35:07 -0400 2023-08-03 A 525 a 17,486 direct

    BREEDEN RICHARD C - Director

    		2023-08-07 16:35:07 -0400 2023-08-03 A 364 $225.50 a 17,850 direct

    BREEDEN RICHARD C - Director

    		2023-08-07 16:35:07 -0400 2023-08-03 A 326 $76.72 a 1,870 direct

    HOLLAND CHRISTOPHER S - Director

    		2023-08-07 16:35:08 -0400 2023-08-03 A 1,544 a 1,544 direct

    HOLLAND CHRISTOPHER S - Director

    		2023-08-07 16:35:08 -0400 2023-08-03 A 525 a 3,989 direct

    MARTIN PAUL EDWARD - Director

    		2023-08-07 16:35:12 -0400 2023-08-03 A 1,050 a 3,581 direct

    FELDMANN CYNTHIA L - Director

    		2023-08-07 16:35:15 -0400 2023-08-03 A 1,544 a 1,544 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    STERIS PLC STE 2023-09-29 22:15:03 UTC 5.0399 0.2801 3100000
    STERIS PLC STE 2023-09-29 21:45:04 UTC 5.0399 0.2801 3100000
    STERIS PLC STE 2023-09-29 21:15:03 UTC 5.0399 0.2801 3100000
    STERIS PLC STE 2023-09-29 20:45:05 UTC 5.0399 0.2801 3100000
    STERIS PLC STE 2023-09-29 20:15:04 UTC 5.0379 0.2821 3100000
    STERIS PLC STE 2023-09-29 19:45:04 UTC 5.0379 0.2821 3100000
    STERIS PLC STE 2023-09-29 19:15:03 UTC 0.0 0.0 3100000
    STERIS PLC STE 2023-09-29 18:45:03 UTC 0.0 0.0 3100000
    STERIS PLC STE 2023-09-29 18:15:03 UTC 0.0 0.0 3100000
    STERIS PLC STE 2023-09-29 17:45:03 UTC 5.0341 0.2859 3100000
    STERIS PLC STE 2023-09-29 17:15:04 UTC 5.0341 0.2859 3100000
    STERIS PLC STE 2023-09-29 16:45:04 UTC 5.0364 0.2836 3100000
    STERIS PLC STE 2023-09-29 16:15:03 UTC 5.0364 0.2836 3100000
    STERIS PLC STE 2023-09-29 15:45:04 UTC 5.0383 0.2817 3100000
    STERIS PLC STE 2023-09-29 15:15:04 UTC 5.0383 0.2817 3100000
    STERIS PLC STE 2023-09-29 14:45:04 UTC 5.0411 0.2789 3100000
    STERIS PLC STE 2023-09-29 14:15:04 UTC 5.0411 0.2789 3100000
    STERIS PLC STE 2023-09-29 13:45:03 UTC 5.07 0.25 3100000
    STERIS PLC STE 2023-09-29 13:15:04 UTC 5.07 0.25 3100000
    STERIS PLC STE 2023-09-29 12:45:05 UTC 5.07 0.25 3100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Absolute 500 Core Fund STE -9.0 shares, $-1259.73 2020-03-31 N-PORT
    FundVantage Trust- Gotham Master Neutral Fund STE -13.0 shares, $-2290.47 2020-09-30 N-PORT
    FundVantage Trust- Gotham Neutral 500 Fund STE -3.0 shares, $-571.44 2021-03-31 N-PORT
    Nuveen Investment Trust- Nuveen Equity Market Neutral Fund STE -1000.0 shares, $-190860.0 2021-05-31 N-PORT
    FundVantage Trust- Gotham Hedged Plus Fund STE -92.0 shares, $-16991.48 2022-12-30 N-PORT
    Nuveen Investment Trust II- Nuveen Equity Long/Short Fund STE -1400.0 shares, $-279958.0 2023-05-31 N-PORT
    Trust for Professional Managers- Convergence Long/Short Equity ETF STE -345.0 shares, $-68989.65 2023-05-31 N-PORT
    FundVantage Trust- Gotham Hedged Core Fund STE -66.0 shares, $-14848.68 2023-06-30 N-PORT
    FundVantage Trust- Gotham Enhanced 500 Plus Fund STE -22.0 shares, $-4949.56 2023-06-30 N-PORT
    Legg Mason Global Asset Management Trust- Franklin Global Market Neutral Fund STE -700.0 shares, $-157486.0 2023-06-30 N-PORT
    Leuthold Funds Inc- Leuthold Core Investment Fund STE -3261.0 shares, $-733659.78 2023-06-30 N-PORT
    Leuthold Funds Inc- Leuthold Grizzly Short Fund STE -6103.0 shares, $-1373052.94 2023-06-30 N-PORT
    Leuthold Funds Inc- Leuthold Global Fund STE -86.0 shares, $-19348.28 2023-06-30 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund STE -300.0 shares, $-67494.0 2023-06-30 N-PORT
    INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund STE -695.0 shares, $-156361.1 2023-06-30 N-PORT
    GMO TRUST- GMO Strategic Opportunities Allocation Fund STE -100.0 shares, $-19997.0 2023-05-31 N-PORT
    Steward Funds Inc- Steward Equity Market Neutral Fund STE -3500.0 shares, $-789425.0 2023-07-31 N-PORT
    First Trust Exchange-Traded Fund III- First Trust Long/Short Equity ETF STE -5614.0 shares, $-1266237.7 2023-07-31 N-PORT
    CLOUGH GLOBAL EQUITY FUND- Clough Global Equity Fund STE -2795.0 shares, $-630412.25 2023-07-31 N-PORT
    CLOUGH GLOBAL OPPORTUNITIES FUND- Clough Global Opportunities Fund STE -5095.0 shares, $-1149177.25 2023-07-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments